The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Prime Medicine Inc shares valued at $23,790 were purchased by Brudnick Richard on May 20 ’25. At $1.19 per share, Brudnick Richard acquired 20,000 shares. The insider’s holdings grew to 20,000 shares worth approximately $26400.0 following the completion of this transaction.
Also, LEE ANN L. purchased 100,000 shares, netting a total of over 113,000 in proceeds. Following the buying of shares at $1.13 each, the insider now holds 100,000 shares.
Before that, Reine Allan had added 125,000 shares to its account. In a trade valued at $147,150, the Chief Executive Officer bought Prime Medicine Inc shares for $1.18 each. Upon closing the transaction, the insider’s holdings increased to 125,000 shares, worth approximately $0.17 million.
As published in a research note from Citigroup on May 27, 2025, Prime Medicine Inc [PRME] has been rated down from a Buy to a Neutral and the price target has been revised to $1.50. Analysts at JP Morgan downgraded the stock from ‘”an Overweight”‘ to ‘”a Neutral”‘ outlook in a report released in mid May. As of May 20, 2025, H.C. Wainwright has decreased its “Buy” rating to a “Neutral” for PRME. Earlier on December 10, 2024, JMP Securities initiated its rating. Their recommendation was “a Mkt outperform” for PRME stock.
Analyzing PRME Stock Performance
During the last five days, there has been a surge of approximately 3.94%. Over the course of the year, Prime Medicine Inc shares have dropped approximately -54.79%. Shares of the company reached a 52-week high of $3.5900 on 01/06/25 and a 52-week low of $1.1100 on 05/22/25.
Support And Resistance Levels for Prime Medicine Inc (PRME)
According to the 24-hour chart, there is a support level at 1.2900, which, if violated, would cause prices to drop to 1.2600. In the upper region, resistance lies at 1.3500. The next price resistance is at 1.3800. RSI (Relative Strength Index) is 48.13 on the 14-day chart, showing neutral technical sentiment.
Which companies own the most shares of Prime Medicine Inc (PRME)?
On May 20, 2024, H.C. Wainwright assigned a price target of “a Buy” to the stock and initiated coverage with a $10.
